MedPath

SANDOZ FESOTERODINE FUMARATE

SANDOZ FESOTERODINE FUMARATE

Approved
DIN Number

02521776

Drug Class

Human

Market Date

May 2, 2022

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02521776
AIG Number0153091002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G04BD11 FESOTERODINE
Product Specifications
Dosage FormTablet (Extended-Release)
Route of AdministrationOral
AHFS Classification86:12.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

FESOTERODINE FUMARATEActive
Strength: 8 MG
Monograph: FESOTERODINE FUMARATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.